944 results on '"Hide, Michihiro"'
Search Results
2. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus
3. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
4. Mathematical-based morphological classification of skin eruptions corresponding to the pathophysiological state of chronic spontaneous urticaria
5. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan
6. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
7. Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
8. A Staphylococcus epidermidis strain inhibits the uptake of Staphylococcus aureus derived from atopic dermatitis skin into the keratinocytes
9. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
10. Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria
11. Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheat
12. Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study
13. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey
14. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
15. Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
16. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
17. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021
18. Clinical and histological characterization of transient dermal pain triggered by sweating stimuli
19. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors
20. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.
21. A novel detection method for cross-linking of IgE-receptors by autoantibodies in chronic spontaneous urticaria
22. The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)
23. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)
24. Survey of hereditary angioedema episodes and quality of life impairment through a patient-participatory registry
25. A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)
26. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
27. Gender disparities in academic dermatology in Japan: Results from the first national survey
28. The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey
29. Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema
30. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
31. CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
32. Recurrent Wheals When He Exercised
33. Japanese guidelines for atopic dermatitis 2020
34. Roles of omalizumab in various allergic diseases
35. Type-I-hypersensitivity to 15 kDa, 28 kDa and 54 kDa proteins in vitellogenin specific to Gadus chalcogrammus roe
36. Clinical utility of the basophil activation test in the diagnosis of sweat allergy
37. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study
38. Management of urticarial vasculitis: A worldwide physician perspective
39. Decreased intracellular histamine concentration and basophil activation in anaphylaxis
40. Dupilumab Reduces Disease Activity in Patients with Chronic Spontaneous Urticaria: LIBERTY-CSU CUPID Study A
41. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies
42. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
43. Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma
44. Complicated cutaneous leishmaniasis caused by an imported case of Leishmania tropica in Japan: a case report
45. The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project
46. Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosis
47. Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
48. HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy
49. Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity
50. Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.